ATE342504T1 - Ionenkanal-testverfahren - Google Patents

Ionenkanal-testverfahren

Info

Publication number
ATE342504T1
ATE342504T1 AT01953433T AT01953433T ATE342504T1 AT E342504 T1 ATE342504 T1 AT E342504T1 AT 01953433 T AT01953433 T AT 01953433T AT 01953433 T AT01953433 T AT 01953433T AT E342504 T1 ATE342504 T1 AT E342504T1
Authority
AT
Austria
Prior art keywords
ion channel
test procedure
channel test
candidate compound
cells
Prior art date
Application number
AT01953433T
Other languages
English (en)
Inventor
Michael P Maher
Jesus E Gonzalez Iii
Original Assignee
Vertex Pharma San Diego Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/804,480 external-priority patent/US7312043B2/en
Application filed by Vertex Pharma San Diego Llc filed Critical Vertex Pharma San Diego Llc
Application granted granted Critical
Publication of ATE342504T1 publication Critical patent/ATE342504T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01953433T 2000-07-10 2001-07-09 Ionenkanal-testverfahren ATE342504T1 (de)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US21766600P 2000-07-10 2000-07-10
US21767100P 2000-07-10 2000-07-10
US21722100P 2000-07-10 2000-07-10
US21721900P 2000-07-10 2000-07-10
US09/804,480 US7312043B2 (en) 2000-07-10 2001-03-12 Ion channel assay methods
US09/804,458 US6969449B2 (en) 2000-07-10 2001-03-12 Multi-well plate and electrode assemblies for ion channel assays
US09/804,580 US6686193B2 (en) 2000-07-10 2001-03-12 High throughput method and system for screening candidate compounds for activity against target ion channels
US09/804,457 US7399599B2 (en) 2000-07-10 2001-03-12 Ion channel assay methods

Publications (1)

Publication Number Publication Date
ATE342504T1 true ATE342504T1 (de) 2006-11-15

Family

ID=27575195

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01953433T ATE342504T1 (de) 2000-07-10 2001-07-09 Ionenkanal-testverfahren
AT06019986T ATE480771T1 (de) 2000-07-10 2001-07-09 Ionenkanal-assayverfahren

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06019986T ATE480771T1 (de) 2000-07-10 2001-07-09 Ionenkanal-assayverfahren

Country Status (10)

Country Link
EP (2) EP1303757B1 (de)
JP (1) JP5209835B2 (de)
AT (2) ATE342504T1 (de)
AU (4) AU2001275881B2 (de)
CA (1) CA2413711C (de)
DE (2) DE60143064D1 (de)
DK (1) DK1303757T3 (de)
ES (1) ES2273868T3 (de)
MX (1) MXJL03000001A (de)
WO (1) WO2002008748A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244349B2 (en) 1997-12-17 2007-07-17 Molecular Devices Corporation Multiaperture sample positioning and analysis system
US20020144905A1 (en) 1997-12-17 2002-10-10 Christian Schmidt Sample positioning and analysis system
US7615356B2 (en) * 2000-07-10 2009-11-10 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
EP1303757B1 (de) * 2000-07-10 2006-10-11 Vertex Pharmaceuticals (San Diego) LLC Ionenkanal-testverfahren
US7067046B2 (en) 2000-08-04 2006-06-27 Essen Instruments, Inc. System for rapid chemical activation in high-throughput electrophysiological measurements
WO2003006103A2 (en) * 2001-07-12 2003-01-23 Merck & Co., Inc. Electrical field stimulation of eukaryotic cells
WO2003035824A1 (en) * 2001-10-25 2003-05-01 Bar-Ilan University Interactive transparent individual cells biochip processor
JP2005517180A (ja) * 2002-02-05 2005-06-09 ザ ユニヴァーシティー コート オブ ザ ユニヴァーシティー オブ グラスゴー 細胞検定を実施するための装置
WO2004039489A2 (en) * 2002-11-01 2004-05-13 Cellectricon Ab Computer programs,workstations, systems and methods for microfluidic substrates in cell
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
DE502004009820D1 (de) * 2004-03-15 2009-09-10 Lonza Cologne Ag Behältnis und Vorrichtung zur Erzeugung von elektrischen Feldern in einzelnen Reaktionsräumen
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
GB0723725D0 (en) * 2007-12-05 2008-01-16 Ge Healthcare Uk Ltd Apparatus and method for detecting dna damage
EP2237887A2 (de) 2007-12-26 2010-10-13 Seng Enterprises Ltd. Vorrichtung zur untersuchung von lebenden zellen
AU2009257271A1 (en) * 2008-06-13 2009-12-17 Scott & White Healthcare Characterization of biological samples
US8221411B2 (en) * 2008-07-28 2012-07-17 Medtronic, Inc. Systems and methods for cardiac tissue electroporation ablation
EP2278332A1 (de) 2009-07-20 2011-01-26 Fondazione Centro San Raffaele del Monte Tabor Verfahren zur optischen Messung von Abweichungen der Zellmembranleitfähigkeit
JP5411096B2 (ja) * 2010-08-31 2014-02-12 株式会社堀場製作所 粒子物性測定セル及び粒子物性測定装置
JP6346096B2 (ja) * 2012-10-25 2018-06-20 浜松ホトニクス株式会社 細胞観察装置及び細胞観察方法
JP5778354B2 (ja) * 2012-10-25 2015-09-16 浜松ホトニクス株式会社 細胞観察装置、電気刺激装置、及び細胞観察方法
ES2654393T3 (es) 2013-07-19 2018-02-13 Vertex Pharmaceuticals Incorporated Sulfonamidas como moduladores de los canales de sodio
LT3080134T (lt) 2013-12-13 2018-11-12 Vertex Pharmaceuticals Incorporated Piridono amidų provaistai, naudotini kaip natrio kanalų moduliatoriai
SG10201906952QA (en) * 2014-12-19 2019-09-27 Univ Ottawa Integrating nanopore sensors within microfluidic channel arrays using controlled breakdown
US11358977B2 (en) 2017-05-16 2022-06-14 Vertex Pharmaceuticals Incorporated Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
CN109679844B (zh) * 2017-10-19 2023-08-22 苏州壹达生物科技有限公司 一种流式电穿孔装置
WO2019157505A1 (en) 2018-02-12 2019-08-15 Vertex Pharmaceuticals Incorporated A method of treating pain
WO2020146612A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
CA3164134A1 (en) 2019-12-06 2021-06-10 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
JP2024520643A (ja) 2021-06-04 2024-05-24 バーテックス ファーマシューティカルズ インコーポレイテッド ナトリウムチャネルの調節因子としてのヒドロキシ及び(ハロ)アルコキシ置換テトラヒドロフラン
JP2024520646A (ja) 2021-06-04 2024-05-24 バーテックス ファーマシューティカルズ インコーポレイテッド ナトリウムチャネルのモジュレーターとしてのn-(ヒドロキシアルキル(ヘテロ)アリール)テトラヒドロフランカルボキサミド類似体
SI4347031T1 (sl) 2021-06-04 2026-01-30 Vertex Pharmaceuticals Incorporated N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
MA64856B1 (fr) 2021-06-04 2026-02-27 Vertex Pharmaceuticals Incorporated Formes de dosage solides et regimens de dosage comprenant le [[3-(3,4-difluoro-2-méthoxy-phényl)-4,5-diméthyl-5-(trifluorométhyl) tétrahydrofuranne-2-carbonyl]amino]pyridine-2-carboxamide
DE102021210044A1 (de) 2021-09-10 2023-03-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Messsystem, Probenkörper, Elektrodenvorrichtung und Verfahren zum Messen einer Vielzahl von Analyten
UY40234A (es) 2022-04-22 2023-11-15 Vertex Pharma Compuestos heteroarilo para el tratamiento del dolor
WO2025090465A1 (en) 2023-10-23 2025-05-01 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
US20250134571A1 (en) * 2023-10-25 2025-05-01 St. Jude Medical, Cardiology Division, Inc. Systems and methods for reducing microbubbles in electroporation applications
US20260001877A1 (en) 2024-06-28 2026-01-01 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067951A (en) * 1975-11-19 1978-01-10 Bactomatic Inc. Process for making impedance measuring module
US4970154A (en) * 1987-10-09 1990-11-13 Baylor College Of Medicine Method for inserting foreign genes into cells using pulsed radiofrequency
US5187096A (en) * 1991-08-08 1993-02-16 Rensselaer Polytechnic Institute Cell substrate electrical impedance sensor with multiple electrode array
JP3099049B2 (ja) * 1992-07-29 2000-10-16 農林水産省果樹試験場長 電気的細胞融合及び電気的核酸導入のための大量処理用電極
US5661035A (en) * 1995-06-07 1997-08-26 The Regents Of The University Of California Voltage sensing by fluorescence resonance energy transfer
DE19529371C3 (de) * 1995-08-10 2003-05-28 Nmi Univ Tuebingen Mikroelektroden-Anordnung
ATE336610T1 (de) * 1996-05-15 2006-09-15 Hyperion Catalysis Int Nanofasern mit grossen oberflächen
US5972694A (en) * 1997-02-11 1999-10-26 Mathus; Gregory Multi-well plate
US5981268A (en) * 1997-05-30 1999-11-09 Board Of Trustees, Leland Stanford, Jr. University Hybrid biosensors
WO2000034434A1 (en) * 1998-12-07 2000-06-15 Acacia Biosciences, Inc. Multi-channel electrode arrays
US6686193B2 (en) * 2000-07-10 2004-02-03 Vertex Pharmaceuticals, Inc. High throughput method and system for screening candidate compounds for activity against target ion channels
EP1303757B1 (de) * 2000-07-10 2006-10-11 Vertex Pharmaceuticals (San Diego) LLC Ionenkanal-testverfahren

Also Published As

Publication number Publication date
EP1757932A3 (de) 2007-07-18
CA2413711A1 (en) 2002-01-31
DK1303757T3 (da) 2007-02-05
AU2006202851B2 (en) 2009-06-04
AU7588101A (en) 2002-02-05
ATE480771T1 (de) 2010-09-15
WO2002008748A3 (en) 2002-05-02
DE60143064D1 (de) 2010-10-21
WO2002008748A2 (en) 2002-01-31
EP1303757B1 (de) 2006-10-11
AU2009212941A1 (en) 2009-10-01
AU2006202851A1 (en) 2006-07-27
JP5209835B2 (ja) 2013-06-12
ES2273868T3 (es) 2007-05-16
EP1303757A2 (de) 2003-04-23
CA2413711C (en) 2012-03-13
DE60123797D1 (de) 2006-11-23
WO2002008748A9 (en) 2003-06-12
DE60123797T2 (de) 2007-10-18
MXJL03000001A (es) 2004-02-09
JP2004514115A (ja) 2004-05-13
AU2009212941B2 (en) 2012-06-28
EP1757932A2 (de) 2007-02-28
EP1757932B1 (de) 2010-09-08
AU2001275881B2 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
ATE342504T1 (de) Ionenkanal-testverfahren
WO2005022113A3 (en) Ion channel assay methods
DE60238493D1 (de) Is von seltenen zellen verwendete markierte zellen
DE60040335D1 (de) Derivatisierte nukleinsäuren und deren verwendung
DE60124301D1 (de) Dünnschichtelektroden zum feststellen von herzdepolarisationsignalen
DK1032705T3 (da) Probearrays og fremgangsmåder til at benytte probearrays til at skelne mellem DNA
ATE275194T1 (de) Makroeingekapselte sekretorische zellen
DE69841285D1 (de) Bipolares Elektrodeninstrument
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
BR9607193B1 (pt) teste de eletroquimioluscÊncia multi-especÍfico de méltiplos conjuntos.
EP1036320A4 (de) Verbesserte elektrochemische biosensor-teststreifen
DE60128841D1 (de) Schirmblech für eine elektro-chirurgische Elektrode
ATE289065T1 (de) Verfahren und vorrichtung zur ortung und konzentration von polaren analyten mittels eines elektrischen wechselfeldes
DE69632447D1 (de) Analysator zur Analyse von Urinbestandteilen
DE60136335D1 (de) Parallele genotypisierung mehrerer patientenproben
ATE418729T1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
DE69513054D1 (de) Herstellungsverfahren einer elektrode für eine elektrochemische vorrichtung
WO2002093129A3 (en) Methods for analyzing interactions between proteins in live and intact cells
DE60103428D1 (de) Identifizierung von zellen während kinetischer versuchsreihen
DE60108504D1 (de) Kathodenanordnung für eine indirekt geheizte kathode einer ionenquelle
DE69907182D1 (de) Elektrochemische zelle
AU1810101A (en) Capillary electrophoresis probes and method
AR005342A1 (es) Metodo para la manufactura de felodipina
DE59900628D1 (de) Nachvernetzung von hydrogelen mittels borsäureestern
EP1312915A4 (de) Elektrophorese-analyseverfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1303757

Country of ref document: EP